Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TollB-001 in Systemic Sclerosis
NCT07745725Phase 2Not yet recruiting
- Sponsor
- Toll Biotech Co., Ltd.
- Start
- Aug 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of tollb-001 in systemic sclerosis (SSc), sponsored by Toll Biotech Co., Ltd.. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
tollb-001
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT07745725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07745725.